Immunogenic compositions comprising human immunodeficiency virus (HIV) mosaic Nef proteins
View Patent ↗The present invention relates to mosaic clade M HIV-1 Nef polypeptides and to compositions comprising same. The polypeptides of the invention are suitable for use in inducing an immune response to HIV-1 in a human.
1. An isolated mosaic clade M human immunodeficiency virus type 1 (HIV-1) Nef polypeptide comprising an amino acid sequence selected from the group consisting of Nef coreM 4.1 (SEQ ID NO:33), Nef coreM 4.2 (SEQ ID NO:34), Nef coreM 4.3 (SEQ ID NO:35), and Nef coreM 4.4 (SEQ ID NO:36).
2. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid sequence of Nef coreM 4.1 (SEQ ID NO:33).
3. A composition comprising at least one polypeptide according to claim 1 and a carrier.
4. A method of inducing an immune response in a mammal comprising administering to said mammal an amount of at least one polypeptide according to claim 1 sufficient to effect said induction.
5. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid sequence of Nef coreM 4.2 (SEQ ID NO:34).
6. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid sequence of Nef coreM 4.3 (SEQ ID NO:35).
7. The polypeptide according to claim 1 wherein said polypeptide comprises the amino acid sequence of Nef coreM 4.4 (SEQ ID NO:36).